Eignapharma is a company operating in the pharmaceutical business engaged in providing services to the industry peers, especially qualified and experienced in Business Development, Pharmacovigilance, Regulatory Affairs, GxP Compliance.

Eignapharma is your partner of choice to:

Identify the best business partners.

Identify the best product/source fit.

Ensure European Pharmacovigilance Compliance.

Meet the European GMP/GDP standards.

Prepare, submit and/or maintain Marketing Authorisations in Europe.

8th Annual Pharmacovigilance Forum – April 3-5 2019, Bratislava

Our Pharmacovigilance Director will be attending the 8th Annual Pharmacovigilance Forum to be held in Bratislava next week within the ‘Future of Healt Summit’ , where relevant experts and speakers from both EU and non-EU Pharma companies will be discussing new...

CPhI South East Asia

Eignapharma participate in the upcoming CPhI South East Asia scheduled to take place in Bangkok, Thailand from March 12thto 14th 2019. We look forward to making new friends and entertaining profitable meetings.

Use of mobile technologies to scan labelling and PL of medicinal products

Eignapharma participate in the upcoming CPhI South East Asia scheduled to take place in Bangkok, Thailand from March 12thto 14th 2019. We look forward to making new friends and entertaining profitable meetings.

Launch of the new EudraVigilance System: Q&A from stakeholders

Our Pharmacovigilance Director will be attending the 8th Annual Pharmacovigilance Forum to be held in Bratislava next week within the ‘Future of Healt Summit’ , where relevant experts and speakers from both EU and non-EU Pharma companies will be discussing new...

Premis Creatic 2018

Our Pharmacovigilance Director will be attending the 8th Annual Pharmacovigilance Forum to be held in Bratislava next week within the ‘Future of Healt Summit’ , where relevant experts and speakers from both EU and non-EU Pharma companies will be discussing new...

World Antibiotic Awareness Week (12-18 November 2018)

Our Pharmacovigilance Director will be attending the 8th Annual Pharmacovigilance Forum to be held in Bratislava next week within the ‘Future of Healt Summit’ , where relevant experts and speakers from both EU and non-EU Pharma companies will be discussing new...

Workshop on Electronic Product Information (ePI)

Our Pharmacovigilance Director will be attending the 8th Annual Pharmacovigilance Forum to be held in Bratislava next week within the ‘Future of Healt Summit’ , where relevant experts and speakers from both EU and non-EU Pharma companies will be discussing new...

SPOR implementation

Our Pharmacovigilance Director will be attending the 8th Annual Pharmacovigilance Forum to be held in Bratislava next week within the ‘Future of Healt Summit’ , where relevant experts and speakers from both EU and non-EU Pharma companies will be discussing new...

Fluoroquinolone and quinolone antibiotics

The EMA has updated their Q&A document on the new EV System; new questions have been added (collected from the Service Desk and from EMA webinars held), and several responses have been updated. The EMA recommends consulting this document before contacting the...

Monitoring of signals evaluated by the FDA

The EMA has published a document containing the principles and rules of procedure to use mobile technologies to scan the labelling and package leaflet (PL), so patients and healthcare professionals have a different option to obtain statutory or additional information...
v

Connect

+34 93 169 65 51
info@eignapharma.com

Location

Av. Ernest Lluch, 32-TecnoCampus
Tower TCM2 6th floor
08302 Mataró – Barcelona (Spain)